Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting.
Tutschka
P J
PJ
Department of Internal Medicine, Ohio State University, Columbus.
D000206:Actuarial Analysis; D000328:Adult; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D016207:Cytokines / Q000378:metabolism; D005047:Etoposide; D006086:Graft vs Host Disease / Q000453:epidemiology; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012074:Remission Induction; D013577:Syndrome; D016896:Treatment Outcome; D014916:Whole-Body Irradiation / Q000009:adverse effects
D016207:Cytokines; D005047:Etoposide; D003520:Cyclophosphamide; D002066:Busulfan